Does LUSPATERCEPT Cause Off label use? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Off label use have been filed in association with LUSPATERCEPT (Reblozyl). This represents 4.6% of all adverse event reports for LUSPATERCEPT.
12
Reports of Off label use with LUSPATERCEPT
4.6%
of all LUSPATERCEPT reports
2
Deaths
4
Hospitalizations
How Dangerous Is Off label use From LUSPATERCEPT?
Of the 12 reports, 2 (16.7%) resulted in death, 4 (33.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUSPATERCEPT. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does LUSPATERCEPT Cause?
Death (16)
Fatigue (11)
Anaemia (10)
Extramedullary haemopoiesis (10)
Pneumonia (10)
Drug ineffective (9)
Haemoglobin decreased (9)
Thrombocytopenia (9)
Cerebrovascular accident (8)
Covid-19 (8)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LUSPATERCEPT Alternatives Have Lower Off label use Risk?
LUSPATERCEPT vs LUSPATERCEPT-AAMT
LUSPATERCEPT vs LUTEIN
LUSPATERCEPT vs LUTETIUM LU-177
LUSPATERCEPT vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
LUSPATERCEPT vs LUTETIUM OXODOTREOTIDE LU-177